Our top pick for
Stryker Corporation is a medical devices business based in the US. Stryker Corporation shares (SYK) are listed on the NYSE and all prices are listed in US Dollars. Stryker Corporation employs 40,000 staff and has a trailing 12-month revenue of around USD$14.1 billion.
Since the stock market crash in March caused by coronavirus, Stryker Corporation's share price has had significant negative movement.
Its last market close was USD$224.05, which is 0.11% down on its pre-crash value of USD$224.3 and 79.90% up on the lowest point reached during the March crash when the shares fell as low as USD$124.54.
If you had bought USD$1,000 worth of Stryker Corporation shares at the start of February 2020, those shares would have been worth USD$598.35 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,059.76.
|Latest market close||USD$224.05|
|52-week range||USD$124.54 - USD$227.39|
|50-day moving average||USD$209.1657|
|200-day moving average||USD$192.7722|
|Wall St. target price||USD$221.83|
|Dividend yield||USD$2.3 (1.04%)|
|Earnings per share (TTM)||USD$4.21|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-19)||N/A|
|1 month (2020-10-30)||10.91%|
|3 months (2020-08-28)||13.04%|
|6 months (2020-05-26)||N/A|
|1 year (2019-11-26)||N/A|
|2 years (2018-11-26)||N/A|
|3 years (2017-11-26)||N/A|
|5 years (2015-11-26)||N/A|
Valuing Stryker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stryker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stryker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 53x. In other words, Stryker Corporation shares trade at around 53x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Stryker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.0715. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stryker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stryker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$3.7 billion.
The EBITDA is a measure of a Stryker Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$14.1 billion|
|Operating margin TTM||20.75%|
|Gross profit TTM||USD$9.8 billion|
|Return on assets TTM||6.31%|
|Return on equity TTM||12.97%|
|Market capitalisation||USD$83 billion|
TTM: trailing 12 months
There are currently 4.2 million Stryker Corporation shares held short by investors – that's known as Stryker Corporation's "short interest". This figure is 30.4% up from 3.2 million last month.
There are a few different ways that this level of interest in shorting Stryker Corporation shares can be evaluated.
Stryker Corporation's "short interest ratio" (SIR) is the quantity of Stryker Corporation shares currently shorted divided by the average quantity of Stryker Corporation shares traded daily (recently around 1.3 million). Stryker Corporation's SIR currently stands at 3.11. In other words for every 100,000 Stryker Corporation shares traded daily on the market, roughly 3110 shares are currently held short.
However Stryker Corporation's short interest can also be evaluated against the total number of Stryker Corporation shares, or, against the total number of tradable Stryker Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stryker Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Stryker Corporation shares in existence, roughly 10 shares are currently held short) or 0.0127% of the tradable shares (for every 100,000 tradable Stryker Corporation shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stryker Corporation.
Find out more about how you can short Stryker Corporation stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stryker Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 33.93
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stryker Corporation's overall score of 33.93 (as at 10/01/2020) is pretty weak – landing it in it in the 71st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Stryker Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.06/100
Stryker Corporation's environmental score of 3.06 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 14.68/100
Stryker Corporation's social score of 14.68 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.19/100
Stryker Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Stryker Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Stryker Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Stryker Corporation hasn't always managed to keep its nose clean.
|Total ESG score||33.93|
|Total ESG percentile||70.66|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Dividend payout ratio: 33.43% of net profits
Recently Stryker Corporation has paid out, on average, around 33.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.04% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stryker Corporation shareholders could enjoy a 1.04% return on their shares, in the form of dividend payments. In Stryker Corporation's case, that would currently equate to about $2.3 per share.
While Stryker Corporation's payout ratio might seem fairly standard, it's worth remembering that Stryker Corporation may be investing much of the rest of its net profits in future growth.
Stryker Corporation's most recent dividend payout was on 30 October 2020. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2020 (the "ex-dividend date").
Stryker Corporation's shares were split on a 2:1 basis on 17 May 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stryker Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stryker Corporation shares which in turn could have impacted Stryker Corporation's share price.
Over the last 12 months, Stryker Corporation's shares have ranged in value from as little as $124.54 up to $227.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stryker Corporation's is 0.791. This would suggest that Stryker Corporation's shares are less volatile than average (for this exchange).
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Steps to owning and managing CCF, with 24-hour and historical pricing before you buy.
Steps to owning and managing CDW, with 24-hour and historical pricing before you buy.
Steps to owning and managing CWH, with 24-hour and historical pricing before you buy.
Steps to owning and managing CBIO, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing CVGW, with 24-hour and historical pricing before you buy.
Steps to owning and managing AEGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing AJG, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABB, with 24-hour and historical pricing before you buy.
Steps to owning and managing YGYI, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.